News tagged with disease progression
Can heart disease treatments combat AMD?
Dec 01, 2009 |
3 / 5 (1) |
1
Can treatments that reduce risks for cardiovascular disease (CVD) also help combat age-related macular degeneration (AMD), an eye disease that affects millions of Americans? CVD and AMD share some risk factors-such as smoking, ...
Scientists gain new understanding of disease-causing bacteria
Nov 30, 2009 |
not rated yet |
0
A team of scientists from The Forsyth Institute, the University of Connecticut Health Center, the CDC and the Wadsworth Center, have used state-of-the-art technology to elucidate the molecular architecture of Treponema pallidum, ...
Compound shows potential for slowing progression of ALS
Oct 19, 2009 |
not rated yet |
0
A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, in mice. The results offer a bit of good news in ...
Rasagiline drug might slow Parkinson's
Sep 23, 2009 |
4 / 5 (1) |
0
Following one of the largest studies ever conducted in Parkinson's disease (PD), researchers at Mount Sinai School of Medicine report today in The New England Journal of Medicine that rasagiline, a drug currently used to tre ...
Blood test helps guide treatment and can impact quality of life for breast cancer patients
Sep 14, 2009 |
not rated yet |
0
With the goal of tailoring cancer interventions for the individual, researchers at the Lombardi Comprehensive Cancer Center at Georgetown have published the results of a prospective study that validates the use of a simple ...
Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percent
Sep 22, 2009 |
not rated yet |
0
Patients with advanced non-small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13% less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail ...
Tumor size and level of visceral pleura invasion can impact survival of NSCLC patients
Aug 19, 2009 |
not rated yet |
0
A study published in the August 2009 edition of the Journal of Thoracic Oncology found that non-small cell lung cancer (NSCLC) patients could be more accurately staged at diagnosis by taking into account the level of vis ...
Multiple sclerosis progression can be predicted with MRI
Nov 05, 2008 |
4 / 5 (1) |
0
A new study published in Journal of Neuroimaging shows that MRI scans used on multiple sclerosis (MS) patients to determine if the disease has affected gray matter in the brain can identify those at-risk for progression of dis ...
Study shows drug combination improves outcome for advanced non-small cell lung cancer
May 31, 2009 |
5 / 5 (1) |
0
A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer (NSCLC). Results from the Phase III "ATLAS" trial were presented today by ...
A new measure for the malignancy of melanoma
Mar 12, 2009 |
not rated yet |
0
Every tumor, starting from a size of a few millimeters, depends on a supply of nutrients and oxygen. Therefore, using special growth factors, it induces vascular wall cells of neighboring blood vessels to sprout new capillaries ...
Studies show novel device may enhance chemotherapy treatment in brain tumors
Nov 24, 2008 |
4.7 / 5 (3) |
1
NovoCure Ltd. presented results yesterday evaluating the Novo-TTF device in vitro and in a pilot clinical trial that showed the device enhanced the efficacy of standard chemotherapy (temozolomide) treatment in newly-diagnosed ...
